Neurontin side effects

All medicines may cause side effect. Check with your doctor if any of the neurontin side effects mentioned becomes bothersome when using Neurontin.

Neurontin side effects like severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); abnormal thoughts; back and forth eye movements; behavioral problems; change in school performance; chest pain; confusion; fainting; fast, slow, or irregular heartbeat; fever, chills, or sore throat; hyperactivity; loss of coordination; memory loss; new or worsening mental  like depression, agitation, anxiety, panic attacks, aggressiveness, impulsiveness, irritability, hostility, exaggerated feeling of well-being, restlessness, inability to sit still); new or worsening seizures; numbness of an arm or leg; one-sided weakness; severe or persistent headache or dizziness; shortness of breath; speech changes or trouble speaking; suicidal thoughts or actions; swelling of the hands, legs, or feet; tremor; trouble concentrating; twitching; vision changes.

The most commonly observed neurontin side effects associated with the use of Neurontin in adults, not seen at an equivalent frequency among placebo-treated patients, were dizziness, somnolence, and peripheral edema. In the 2 controlled studies in postherpetic neuralgia, 16% of the 336 patients who received Neurontin and 9% of the 227 patients who received placebo discontinued treatment because of neurotin side effects like dizziness, somnolence, and nausea.

The most commonly observed neurontin side effects associated with the use of Neurontin in combination with other antiepileptic drugs in patients >12 years of age, not seen at an equivalent frequency among placebo-treated patients, were somnolence, dizziness, ataxia, fatigue, and nystagmus. The most commonly observed neurontin side effects reported with the use of Neurontin in combination with other antiepileptic drugs in pediatric patients 3 to 12 years of age, not seen at an equal frequency among placebo-treated patients, were viral infection, fever, nausea and/or vomiting, somnolence, and hostility.

Approximately 7% of the 2074 patients >12 years of age and approximately 7% of the 449 pediatric patients 3 to 12 years of age who received Neurontin in premarketing clinical trials discontinued treatment because of neurontin side effects. The neurontin side effects were most commonly associated with withdrawal in patients >12 years of age were somnolence, ataxia, fatigue, nausea and/or vomiting, and dizziness. The neurontin side effects most commonly associated with withdrawal in pediatric patients were emotional liability, hostility, and hyperkinesia.

The overall incidence of neurontin side effects and the types of adverse events seen were similar among men and women treated with Neurontin. The incidence of neurontin side effects increased slightly with increasing age in patients treated with either Neurontin or placebo. Because only 3% of patients (28/921) in placebo-controlled studies were identified as nonwhite (black or other), there are insufficient data to support a statement regarding the distribution of neurontin side effects by race.